BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22986353)

  • 1. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria.
    Lambregts DM; Heijnen LA; Maas M; Rutten IJ; Martens MH; Backes WH; Riedl RG; Bakers FC; Cappendijk VC; Beets GL; Beets-Tan RG
    Abdom Imaging; 2013 Aug; 38(4):720-7. PubMed ID: 22986353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
    Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
    Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?
    Heijnen LA; Lambregts DM; Martens MH; Maas M; Bakers FC; Cappendijk VC; Oliveira P; Lammering G; Riedl RG; Beets GL; Beets-Tan RG
    Eur Radiol; 2014 Feb; 24(2):371-9. PubMed ID: 24051676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
    Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
    Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma.
    Matsuoka H; Nakamura A; Masaki T; Sugiyama M; Nitatori T; Ohkura Y; Sakamoto A; Atomi Y
    Anticancer Res; 2007; 27(5B):3529-33. PubMed ID: 17972513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of gadofosveset-enhanced MRI and multiplanar reformatting for selecting good responders after chemoradiation for rectal cancer.
    Heijnen LA; Maas M; Lahaye MJ; Lalji U; Lambregts DM; Martens MH; Riedl RG; Beets GL; Beets-Tan RG
    Eur Radiol; 2014 Aug; 24(8):1845-52. PubMed ID: 24898096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease.
    McGregor R; Vymazal J; Martinez-Lopez M; Neuwirth J; Salgado P; Beregi JP; Peduto A; de la Pena-Almaguer E; Slater GJ; Shamsi K; Parsons EC
    Eur J Radiol; 2008 Feb; 65(2):316-25. PubMed ID: 17499952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment MRI of lymph nodes in rectal cancer: an opinion-based review.
    Beets-Tan RG
    Colorectal Dis; 2013 Jul; 15(7):781-4. PubMed ID: 23701484
    [No Abstract]   [Full Text] [Related]  

  • 10. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
    Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
    AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer.
    Jao SY; Yang BY; Weng HH; Yeh CH; Lee LW
    Colorectal Dis; 2010 Nov; 12(11):1139-48. PubMed ID: 19548900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of inguinal lymph node metastases using contrast enhanced high resolution MR lymphangiography.
    Liu N; Yan Z; Lu Q; Wang C
    Acad Radiol; 2013 Feb; 20(2):218-23. PubMed ID: 23099240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of gadofosveset-enhanced MR angiography for evaluation of pedal arterial disease: multicenter comparative phase 3 study.
    Bosch E; Kreitner KF; Peirano MF; Thurnher S; Shamsi K; Parsons EC
    AJR Am J Roentgenol; 2008 Jan; 190(1):179-86. PubMed ID: 18094309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation.
    Zhang H; Zhang C; Zheng Z; Ye F; Liu Y; Zou S; Zhou C
    Eur Radiol; 2017 Sep; 27(9):3845-3855. PubMed ID: 28168369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma. what is the optimal criterion?
    Matsuoka H; Nakamura A; Sugiyama M; Hachiya J; Atomi Y; Masaki T
    Anticancer Res; 2004; 24(6):4097-101. PubMed ID: 15736458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat-suppressed gadolinium-enhanced isotropic high-resolution 3D-GRE-T1WI for predicting small node metastases in patients with rectal cancer.
    Chen Y; Yang X; Wen Z; Lu B; Xiao X; Shen B; Yu S
    Cancer Imaging; 2018 May; 18(1):21. PubMed ID: 29784058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
    Rapp JH; Wolff SD; Quinn SF; Soto JA; Meranze SG; Muluk S; Blebea J; Johnson SP; Rofsky NM; Duerinckx A; Foster GS; Kent KC; Moneta G; Middlebrook MR; Narra VR; Toombs BD; Pollak J; Yucel EK; Shamsi K; Weisskoff RM
    Radiology; 2005 Jul; 236(1):71-8. PubMed ID: 15987963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study.
    van Nijnatten TJA; Schipper RJ; Lobbes MBI; van Roozendaal LM; Vöö S; Moossdorff M; Paiman ML; de Vries B; Keymeulen KBMI; Wildberger JE; Smidt ML; Beets-Tan RGH
    Clin Radiol; 2018 Feb; 73(2):168-175. PubMed ID: 29029766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model.
    Lee JY; Choi BI; Son KR; Lee JM; Kim SJ; Park HS; Chang JM; Choi SH; Kim MA; Moon WK
    Radiology; 2012 May; 263(2):391-400. PubMed ID: 22517957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging.
    Ohno Y; Hatabu H; Takenaka D; Higashino T; Watanabe H; Ohbayashi C; Yoshimura M; Satouchi M; Nishimura Y; Sugimura K
    Radiology; 2004 Jun; 231(3):872-9. PubMed ID: 15163823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.